Rhythm Pharmaceuticals Announces Positive Results from Phase 2 Study of Once-weekly Formulation of Setmelanotide in Healthy Obese Volunteers
— Once-weekly formulation of setmelanotide achieved weight loss efficacy comparable to daily-dosing formulation –— Both weekly and daily formulations of […]